Lakewood-Amedex Biotherapeutics, Inc. (LABT)
2.69
-0.61
(-18.48%)
USD |
NASDAQ |
Jul 02, 16:00
2.80
+0.11
(+4.09%)
After-Hours: 19:45
Lakewood-Amedex Biotherapeutics EPS Diluted (Quarterly) : -2.00 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -2.00 |
| December 31, 2025 | -3.90 |
| September 30, 2025 | -2.70 |
| June 30, 2025 | -0.20 |
| March 31, 2025 | -0.10 |
| Date | Value |
|---|---|
| December 31, 2024 | -1.20 |
| September 30, 2024 | -2.80 |
| June 30, 2024 | -0.30 |
| March 31, 2024 | -0.20 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | 2.878 |
| Anixa Biosciences, Inc. | -0.0749 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.9233M |
| Total Expenses (Quarterly) | 0.9233M |
| Enterprise Value | 4.072M |
| Earnings Yield | -327.1% |